Apps JR, Muller HL, Hankinson TC, Yock TI, Martinez-Barbera JP (2023) Contemporary biological insights and clinical management of craniopharyngioma. Endocr Rev 44(3):518–538

Article  PubMed  Google Scholar 

Kiliç M, Can SM, Özdemir B, Tanik C (2019) Management of craniopharyngioma. J Craniofac Surg 30(2):e178–e183

Article  PubMed  Google Scholar 

Müller HL, Merchant TE, Warmuth-Metz M, Martinez-Barbera JP, Puget S (2019) Craniopharyngioma. Nat Rev Dis Primers 5(1):75

Article  PubMed  Google Scholar 

Müller HL (2014) Craniopharyngioma. Endocr Rev 35(3):513–543

Article  PubMed  Google Scholar 

Stamm AC, Vellutini E, Balsalobre L (2011) Craniopharyngioma. Otolaryngol Clin North Am 44(4):937–52

Article  PubMed  Google Scholar 

Garnett MR, Puget S, Grill J, Sainte-Rose C (2007) Craniopharyngioma. Orphanet J Rare Dis 2:18

Article  PubMed  PubMed Central  Google Scholar 

Harsha GS, Dabadghao P, Sudhanshu S (2022) Long-term outcomes of paediatric-onset craniopharyngioma: a retrospective analysis from a tertiary care Centre in North India. Neurol India 70(2):600–605

Article  PubMed  Google Scholar 

Müller HL (2017) Diagnosis, treatment, clinical course, and prognosis of childhood-onset craniopharyngioma patients. Minerva Endocrinol 42(4):356–375

Article  PubMed  Google Scholar 

Gan HW, Morillon P, Albanese A, Aquilina K, Chandler C, Chang YC, Drimtzias E, Farndon S, Jacques TS, Korbonits M, Kuczynski A, Limond J, Robinson L, Simmons I, Thomas N, Thomas S, Thorp N, Vargha-Khadem F, Warren D, Zebian B, Mallucci C, Spoudeas HA (2023) National UK guidelines for the management of paediatric craniopharyngioma. Lancet Diabetes Endocrinol 11(9):694–706

Article  PubMed  Google Scholar 

Henderson F Jr, Schwartz TH (2022) Update on management of craniopharyngiomas. J Neurooncol 156(1):97–108

Article  PubMed  Google Scholar 

Müller HL (2020) The diagnosis and treatment of craniopharyngioma. Neuroendocrinology 110(9–10):753–766

Article  PubMed  Google Scholar 

Gabay S, Merchant TE, Boop FA, Roth J, Constantini S (2023) Shifting strategies in the treatment of pediatric craniopharyngioma. Curr Oncol Rep 25(12):1497–1513

Article  PubMed  Google Scholar 

Erfurth EM (2023) Craniopharyngioma-an update on metabolic and cognitive complications and new therapy. J Intern Med 294(3):269–280

Article  CAS  PubMed  Google Scholar 

Chen A, Ai M, Sun T (2023) Advances in the treatment of adamantinomatous craniopharyngioma: how to balance tumor control and quality of life in the current environment: a narrative review. Front Oncol 13:1326595

Article  PubMed  PubMed Central  Google Scholar 

Agosti E, Zeppieri M, Antonietti S, Piazza A, Ius T, Fontanella MM, Fiorindi A, Panciani PP (2024) Advancing craniopharyngioma management: a systematic review of current targeted therapies and future perspectives. Int J Mol Sci 25(2):743

Iglesias P (2022) Targeted therapies in the medical management of craniopharyngioma. Pituitary 25(3):383–392

Article  CAS  PubMed  Google Scholar 

Müller HL, Merchant TE, Puget S, Martinez-Barbera JP (2017) New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma. Nat Rev Endocrinol 13(5):299–312

Article  PubMed  Google Scholar 

Ma G, Kang J, Qiao N, Zhang B, Chen X, Li G, Gao Z, Gui S (2020) Non-invasive radiomics approach predict invasiveness of adamantinomatous craniopharyngioma before surgery. Front Oncol 10:599888

Article  PubMed  Google Scholar 

Chen B, Chen C, Zhang Y, Huang Z, Wang H, Li R, Xu J (2022) Differentiation between germinoma and craniopharyngioma using radiomics-based machine learning. J Pers Med 12(1):45

Biffi G, Tuveson DA (2021) Diversity and biology of cancer-associated fibroblasts. Physiol Rev 101(1):147–176

Article  CAS  PubMed  Google Scholar 

Pemmasani SK, Atmakuri S, Acharya A (2023) Genome-wide polygenic risk score for type 2 diabetes in Indian population. Sci Rep 13(1):11568

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li X, Sun Z, Peng G, Xiao Y, Guo J, Wu B, Li X, Zhou W, Li J, Li Z, Bai C, Zhao L, Han Q, Zhao RC, Wang X (2022) Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer. Theranostics 12(2):620–638

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cords L, Engler S, Haberecker M, Rüschoff JH, Moch H, de Souza N, Bodenmiller B (2024) Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer. Cancer Cell 42(3):396-412.e5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen X, Song E (2019) Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov 18(2):99–115

Article  CAS  PubMed  Google Scholar 

Shahvali S, Rahiman N, Jaafari MR, Arabi L (2023) Targeting fibroblast activation protein (FAP): advances in CAR-T cell, antibody, and vaccine in cancer immunotherapy. Drug Deliv Transl Res 13(7):2041–2056

Article  CAS  PubMed  Google Scholar 

Nurmik M, Ullmann P, Rodriguez F, Haan S, Letellier E (2020) In search of definitions: cancer-associated fibroblasts and their markers. Int J Cancer 146(4):895–905

Article  CAS  PubMed  Google Scholar 

Fitzgerald AA, Weiner LM (2020) The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev 39(3):783–803

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bughda R, Dimou P, D’Souza RR, Klampatsa A (2021) Fibroblast activation protein (FAP)-targeted CAR-T cells: launching an attack on tumor stroma. Immunotargets Ther 10:313–323

Article  PubMed  PubMed Central  Google Scholar 

Yang X, Lin Y, Shi Y, Li B, Liu W, Yin W, Dang Y, Chu Y, Fan J, He R (2016) FAP promotes Immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling. Cancer Res 76(14):4124–4135

Article  CAS  PubMed  Google Scholar 

Zboralski D, Hoehne A, Bredenbeck A, Schumann A, Nguyen M, Schneider E, Ungewiss J, Paschke M, Haase C, von Hacht JL, Kwan T, Lin KK, Lenore J, Harding TC, Xiao J, Simmons AD, Mohan AM, Beindorff N, Reineke U, Smerling C, Osterkamp F (2022) Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy. Eur J Nucl Med Mol Imaging 49(11):3651–3667

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arçay Öztürk A, Flamen P (2023) FAP-targeted PET imaging in gastrointestinal malignancies: a comprehensive review. Cancer Imaging 23(1):79

Article  PubMed  PubMed Central  Google Scholar 

Hartmann KP, van Gogh M, Freitag PC, Kast F, Nagy-Davidescu G, Borsig L, Plückthun A (2023) FAP-retargeted Ad5 enables in vivo gene delivery to stromal cells in the tumor microenvironment. Mol Ther 31(10):2914–2928

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Y, Liu X, Ainiwan Y, Li M, Pan J, Chen Y, Xiao Z, Wang Z, Xiao X, Tang J, Zeng G, Liang J, Su X, Kungulli R, Fan Y, Lin Q, Liya A, Zheng Y, Chen Z, Xu C, Zhang H, Chen G (2024) Axl as a potential therapeutic target for adamantinomatous craniopharyngiomas: Based on single nucleus RNA-seq and spatial transcriptome profiling. Cancer Lett 592:216905

Article  CAS  PubMed  Google Scholar